Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05350150 · ClinicalTrials.gov registry record · NA

Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study

A NA study of Neuromodulation, sponsored by Northwell Health.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05350150: Recruiting NA study of Neuromodulation, sponsored by Northwell Health.

NCT05350150 is a NA study of Neuromodulation that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 10 participants, below the 45-participant average among 4 other Neuromodulation trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05350150, a NA study of Neuromodulation, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.

Primary Outcome

Sinus cycle length (msec)

Conditions Studied

Interventions

  • DEVICE Auricular Vagal Nerve Stimulation

Study Locations (1)

New York

  • Kristie Coleman - New York

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-08-22
Est. Completion 2025-11-30
Phase NA
Northwell Health

370 total trials

What NCT05350150 shows while recruiting

NCT05350150 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 45-participant average among 4 other Neuromodulation trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Neuromodulation appearing as the primary indexed condition, and to 1 intervention - of which Auricular Vagal Nerve Stimulation is the first listed.

NCT05350150 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05350150 about?

NCT05350150 is a clinical study titled "Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study". The Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study is a single center, pilot, prospective study that aims at evaluating the effects of auricular vagus nerve stimulation (aVNS) on the human cardiac conduction system.

What is the current status of trial NCT05350150?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-08-22. Estimated completion is 2025-11-30.

What conditions does trial NCT05350150 study?

This clinical trial studies the following conditions: Neuromodulation.

What interventions are being tested in trial NCT05350150?

The interventions under investigation include: Auricular Vagal Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05350150?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05350150 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neuromodulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05350150, the US trial registry maintained by the National Library of Medicine. NCT05350150 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.